Rocket Lab's stock trades at $64.26, well below the $111 average target, implying 72.7% upside. Despite a recent rocket test failure delaying the Neutron rocket's debut to late 2026 and causing a 14% drop in shares, the company has a strong $2.36 billion backlog and growing defense contracts. Analyst Erik Rasmussen from Stifel projects the stock could reach $150, more than doubling current prices, based on Neutron's future commercialization, expanding space systems revenue, and government contracts. The key catalyst is Neutron's successful first flight, which could unlock further growth and justify the high valuation, but delays or integration issues could derail the outlook.
The satellite industry is shifting focus from rockets to controlling radio spectrum for direct-to-handset connectivity. The FCC's new Supplemental Coverage from Space authorization enables satellites to beam service directly to ordinary smartphones. ...
Rocket Lab reported $234 million in revenue for Q2, with a backlog rising to $2.36 billion, driven by its Space Systems segment which accounted for 81% of revenue. The company aims to price its Neutron rocket between $50 million and $55 million witho...
ARK Invest, led by Cathie Wood, purchased 705,102 shares of Rocket Lab during a recent stock decline, viewing the dip as a buying opportunity. Rocket Lab, valued at around $38 billion, is a smaller public rival to SpaceX, focusing on small-satellite ...
SpaceX's stock currently trades below its first closing price despite a strong IPO debut, with a consensus analyst target price about 48% higher than the current price. Raymond James analyst Brian Gesuale projects a much more optimistic outlook, sett...
Rocket Lab is recognized for its strong execution in the aerospace sector, consistently beating analyst estimates for eight quarters. However, its stock trades at a high forward Price to Sales ratio of 40x, a significant premium over the sector media...
